Obesity and demographic ageing are two global megatrends that overlap in a particularly unfavorable way in the cardiovascular system. Both factors independently increase the risk of cardiovascular disease, but also interact at common biological levels: from cellular senescence and mitochondrial dysfunction to structural cardiac and vascular remodeling. The state-of-the-art review by Ruperez et al. in the European Heart Journal sheds light on how obesity accelerates biological cardiovascular ageing, which mechanistic intersections can be found and which metabolic therapy strategies – from calorie restriction to GLP-1 receptor agonists and SGLT2 inhibitors – can modulate these processes.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Case study
Wiedemann-Steiner syndrome in a 2-year-old girl
- Chronic back pain
Care in the virtual hospital – the Back@home project
- Psoriatic arthritis
Long-term remission also possible without DMARDs
- Clinical relevance, benefits and limitations
Atrial Fibrillation Screening
- Parkinson's disease: progressive and clinically heterogeneous
Individualized management of motor and non-motor symptoms
- Type 2 diabetes and heart failure: a bidirectional relationship
Proactive preventive measures can reduce the burden of disease
- Dementia
Delirium risks and treatment strategies
- Colorectal cancer screening